Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Possible Role of Inflammatory Serum Biomarkers in Differentiation Between Epileptic Seizure and Psychogenic Non-epileptic Seizure

NCT05571371 is registered in ClinicalTrials.gov with Esraa Mostafa Ahmed Abdel Aal as lead sponsor.

NCT NCT05571371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05571371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Possible Role of Inflammatory Serum Biomarkers in Differentiation Between Epileptic Seizure and Psychogenic Non-epileptic Seizure
Lead sponsor
Esraa Mostafa Ahmed Abdel Aal
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2022
Completion date
November 30, 2024
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, mcp-2: monocyte chemo-attractant protein-2, trail: tumor necrosis factor related apoptosis inducing ligand mcp-2